Core Viewpoint - The commercialization pace of controlled nuclear fusion is currently hindered by funding and technical bottlenecks, and if projects like ITER face delays, the demand for nuclear-grade crown ethers may not materialize as expected by 2026 [1] Company Summary - Kent Catalysts (603120.SH) clarified on an investor interaction platform that its products are not yet applied in the field of controlled nuclear fusion [1]